Elizabeth A. Holmes is President and Chief Executive Officer of Theranos, Inc. Holmes left Stanford University in 2003 at the age of 19 to pursue her company, and she successfully raised $6 million in venture capital from many firms, including Draper Fisher Jurvetson.
Holmes' unique background in microfluidics and nanotechnology led her to found Theranos based on her patent, Medical Device for Analyte Monitoring and Drug Release. The invention and the company are based on her vision to create a new sector of personalized health care that enables individuals to take control of their health through real-time diagnosis, monitoring, and non-invasive treatment of targeted ailments.
She took the company from concept to reality, building a management team and leading the product and commercial development infrastructures.
Previous to Theranos, while Holmes was still in high school, she started a business to distribute C++ software to Asian universities. Holmes has also worked for Genencor International, the Genome Institute Singapore, and she?s acted as Executive Director of Stanford University's Asia Technology Initiative.